Atazanavir Twice Daily

Clinical trial NCT00357721 · COMPLETED

Trial details

NCT number: NCT00357721
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV Infections Protease Inhibitor

Start date: 2006-06-01
Primary completion: 2006-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.